0001752724-21-001881.txt : 20210113 0001752724-21-001881.hdr.sgml : 20210113 20210113134809 ACCESSION NUMBER: 0001752724-21-001881 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201031 FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 EFFECTIVENESS DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCHWAB INVESTMENTS CENTRAL INDEX KEY: 0000869365 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-06200 FILM NUMBER: 21525751 BUSINESS ADDRESS: STREET 1: 211 MAIN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 1-415-667-7000 MAIL ADDRESS: STREET 1: 211 MAIN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 0000869365 S000006807 Schwab 1000 Index Fund C000018433 Schwab 1000 Index Fund SNXFX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0000869365 XXXXXXXX 811-06200 false false false N-1A S000006807 C000018433 SCHWAB INVESTMENTS 811-06200 0000869365 549300V41RCJNTEW5K68 211 MAIN STREET SAN FRANCISCO 94105 US-CA US 800-648-5300 Charles Schwab Investment Management, Inc. 211 Main Street San Francisco 94105 800-648-5300 Investment Adviser and Fund Administrator Records State Street Bank and Trust Company One Lincoln Street Boston 02111 617-786-3000 Custodian Records Schwab Investments 211 Main Street San Francisco 94105 800-648-5300 Trust and Fund Records Charles Schwab & Co., Inc. 211 Main Street San Francisco 94105 800-648-5300 Principal Underwriter Records DST Asset Manager Solutions, Inc. 2000 Crown Colony Drive Quincy 02169 800-407-0256 Transfer Agent Records N N N-1A 8 Y David L. Mahoney 000000000 N Jane P. Moncreiff 000000000 N Walter W. Bettinger II 002915574 Y Joseph R. Martinetto 002996277 Y Nancy F. Heller 001813276 N John F. Cogan 000000000 N Kiran M. Patel 000000000 N Robert W. Burns 000000000 N Kimberly S. Patmore 000000000 N Stephen Timothy Kochis 002293884 N Gerald B. Smith 000500814 N Jonathan de St. Paer 004731700 Y Michael Hogan 002986381 211 Main Street San Francisco 94105 XXXXXX N N N N N N N Charles Schwab & Co., Inc. 8-16514 000005393 549300ZP8XN77GK5BS04 Y N Deloitte & Touche LLP 34 00000000000000000000 Y N N N N N N Schwab 1000 Index Fund S000006807 549300POUDZNU374H849 N 1 0 0 Y N 0.00000000 -0.05000000 0.00000000 0.00000000 N N Y N N Goldman Sachs Bank USA KD3XUN7C6T14HNAYLU02 N N Cash collateral reinvestment fee Revenue sharing split 4402680.34000000 153611.12000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 17a-7 (17 CFR 270.17a-7) N N N N Charles Schwab Investment Management, Inc. 801-35905 000106753 EVQ6EP3QESDF386W4D54 N DST Asset Manager Solutions, Inc. 84-00896 00000000000000000000 N N N ICE Data Services, Inc. 13-3668779 Tax ID N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) State Street Trust Company Canada 549300L71XG2CTQ2V827 CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N DST Asset Manager Solutions, Inc. 84-00896 SEC File Number N N N Charles Schwab Investment Management, Inc. EVQ6EP3QESDF386W4D54 Y N N Charles Schwab & Co., Inc. 8-16514 000005393 549300ZP8XN77GK5BS04 0.00000000 TD Ameritrade Hong Kong Limited N/A 000000000 00000000000000000000 HK 0.00000000 Charles Schwab, Hong Kong, Ltd. N/A 000000000 00000000000000000000 HK 0.00000000 Charles Schwab Singapore Pte. Ltd. N/A 000000000 00000000000000000000 SG 0.00000000 TD Ameritrade, Inc. 8-23395 000007870 CWQYQU0TV2NLMLZKNB44 0.00000000 Charles Schwab, U.K., Limited N/A 000000000 549300PF2KTM8A12FH91 GB 0.00000000 TD Ameritrade Clearing, Inc. 8-16335 000005633 MRK678VXOI09YSSN8X19 0.00000000 TD Ameritrade Singapore Pte. Ltd. N/A 000000000 00000000000000000000 SG 0.00000000 Charles Schwab Australia Pty Limited N/A 000000000 00000000000000000000 AU 0.00000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 15027.55000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 21471.88000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 7631.39000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 8378.32000000 Instinet, LLC 8-23669 000007897 549300MGMN3RKMU8FT57 5733.22000000 Cantor Fitzgerald & Co. 8-201 000000134 5493004J7H4GCPG6OB62 5308.56000000 Cowen and Company, LLC 8-22522 000007616 549300WR155U7DVMIW58 5048.96000000 Kepler Capital Markets, Inc. 8-67194 000139148 254900VCHS9DMDUVZN16 4498.50000000 Jane Street Execution Services, LLC 8-69254 000167280 549300HXJLXCPDWAH070 4991.98000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 10417.67000000 111644.60000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 15124570.02000000 Jefferies LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 391222.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 33347008.99000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 18804881.38000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 169023.00000000 67836705.39000000 N 9458513161.64000000 Uncommitted 400000000.00000000 N Committed 850000000.00000000 N N N N true INTERNAL CONTROL RPT 2 NCEN_2688600509435703.txt REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Trustees of Schwab Investments and Shareholders of Schwab 1000 Index Fund: In planning and performing our audits of the financial statements of Schwab 1000 Index Fund (the "Fund"), as of and for the year ended October 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the trust; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a fund's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of October 31, 2020. This report is intended solely for the information and use of management and Board of Trustees of Schwab Investments and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ Deloitte & Touche LLP Denver, Colorado December 16, 2020